-
October 14, 2022 Treating Postpartum Depression with PsychedelicsPostpartum depression impacts thousands with no good treatment options. Some people are now treating postpartum...
-
September 16, 2022 Adverse Events in Psychedelic Clinical Trials are UnderreportedNew research shows that enthusiasm for psychedelic treatments makes it easy to ignore adverse events...
-
September 8, 2022 What’s in the San Francisco Psychedelics Decrim Resolution?San Francisco becomes the latest city to decriminalize entheogenic plants in another win for Decriminalize...
-
August 22, 2022 How Long Can the Psychedelic Renaissance Last?The Psychedelic Renaissance is now in full effect, but how long can the party last?...
-
August 9, 2022 Psychedelic Clinical Trials and the Michael Pollan EffectWith the incredible popularity of “How to Change Your Mind,” Michael Pollan sells people on...
-
August 8, 2022 Three Phase 3 Clinical Trials that Could Legalize PsychedelicsThe road to psychedelic legalization has many paths. These 3 clinical trials have the best...
-
July 22, 2022 A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 TrialCompass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new...
-
July 19, 2022 Canada Halts MDMA Clinical Trial Over Concerns for Participant SafetyDeficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in...
-
July 14, 2022 How to Change Your Mind Review: The Psychedelic Hype Train Keeps ChuggingThe Netflix documentary 'How to Change Your Mind' is great TV even though it fails...